| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.39B | — | +15.8% |
| Cost of Revenue | $17.67B | — | +9.2% |
| Gross Profit | $4.72B | — | +49.7% |
| R&D Expense | $1.95B | — | +38.1% |
| SG&A Expense | $1.83B | — | +46.5% |
| Operating Income | $941.0M | — | +135.8% |
| Pre-tax Income | $748.0M | — | +27.0% |
| Income Tax | $257.0M | — | +52.1% |
| Net Income | $477.0M | — | +16.6% |
| EPS (Basic) | $0.15 | — | +15.4% |
| EPS (Diluted) | $0.13 | — | +8.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.60B | +0.5% | +1.5% |
| Short-term Investments | $28.14B | +2.2% | +36.3% |
| Accounts Receivable | $3.96B | -13.5% | +4.7% |
| Inventory | $14.43B | +16.5% | +5.3% |
| Current Assets | $69.75B | +1.6% | +17.4% |
| Total Assets | $143.72B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.94B | — | +82.6% |
| Capital Expenditures | $2.49B | — | +67.1% |
| Investing Cash Flow | -$5.02B | — | -204.2% |
| Financing Cash Flow | $1.17B | — | +453.0% |
| Free Cash Flow | $1.44B | — | +117.5% |
| +14.9% |
| Current Liabilities | $34.14B | +7.6% | +14.7% |
| Long-term Debt | $7.64B | +16.1% | +50.5% |
| Total Liabilities | $58.92B | +7.2% | +18.6% |
| Stockholders' Equity | $84.12B | +2.4% | +12.7% |